Pembrolizumab for triple-negative breast cancer
- PMID: 32145769
- DOI: 10.1016/S1470-2045(20)30154-6
Pembrolizumab for triple-negative breast cancer
Comment on
-
Pembrolizumab for Early Triple-Negative Breast Cancer.N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
